MedPath

Psychosocial Treatment for Women With Depression and Pain

Not Applicable
Completed
Conditions
Depression
Pelvic Pain
Interventions
Behavioral: Interpersonal Therapy for Pain (IPT-P)
Behavioral: Enhanced Support and Connection to Counseling
Registration Number
NCT00895999
Lead Sponsor
University of Rochester
Brief Summary

Patients with depression and pain have poorer outcomes in response to depression treatments than depressed patients without pain. While psychotherapy treatment studies have demonstrated improvement in pain and depression, no psychosocial interventions have been developed and tested prospectively specifically for patients with both conditions. Interpersonal psychotherapy (IPT), an effective treatment for depression, has been adapted successfully for physically ill patients and demonstrates good adherence, treatment satisfaction, and depression outcomes. The investigators propose to test a modified form of IPT-P for depressed patients with co-morbid pain.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
60
Inclusion Criteria
  • major depression
  • chronic pelvic pain
Exclusion Criteria
  • current or past psychosis
  • moderate mental retardation or greater
  • active suicidal intent
  • active abuse of non-prescribed substances (< 3 months)
  • current individual psychotherapy
  • current pregnancy
  • terminal illness
  • inability to communicate in English
  • men

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1Interpersonal Therapy for Pain (IPT-P)Female patients (n=30) who meet criteria for major depression and chronic pelvic pain will be randomly assigned to 8 individual sessions of IPT adapted for depression and pain.
2Enhanced Support and Connection to CounselingFemale patients (n=30) who meet criteria for major depression and chronic pelvic pain will be randomly assigned to Enhanced Support and Connection to Counseling (ESCC).
Primary Outcome Measures
NameTimeMethod
A self-report measure BDI and a clinician measure HRSD will evaluate depression severity. These measures are standards in primary care depression trials and in pain studies and have demonstrated sensitivity to detect changes in depress0, 12 wks, 24 wks, 36 wks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Rochester Medical Center

🇺🇸

Rochester, New York, United States

© Copyright 2025. All Rights Reserved by MedPath